Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acceptability of Advanced Chronic Liver Disease Screening by Transient Elstography (Fibroscan ®) in Patients Hospitalised in Psychiatric Unit: a Single Center Prospective Study

NCT05602870 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05602870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05602870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acceptability of Advanced Chronic Liver Disease Screening by Transient Elstography (Fibroscan ®) in Patients Hospitalised in Psychiatric Unit: a Single Center Prospective Study
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
March 7, 2023
Completion date
January 5, 2024
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced chronic liver disease, liver fibrosis, psychiatric disorder, psychiatric hospitalization